Stocktoria
KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · IPO 2025-03-06
KESTRA MEDICAL TECHNOLOGIES, LTD. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $59.8M | $27.8M |
| Gross profit | $24.2M | $362,000 |
| R&D expense | $15.7M | $15.5M |
| SG&A expense | $114.9M | $69.9M |
| Operating income | -$106.4M | -$85.1M |
| Income tax | $135,000 | $24,000 |
| Net income | -$113.8M | -$94.1M |
| EPS (diluted) | $-5.13 | $-5.07 |
| Operating cash flow | -$77.6M | -$72.2M |
| Free cash flow | -$100.5M | -$84.5M |
| Cash & equivalents | $237.6M | $8.2M |
| Total assets | $295.7M | $45.9M |
| Total liabilities | $90.3M | $78.2M |
| Shareholders' equity | $205.4M | -$209.4M |
Source: SEC EDGAR filings · CIK 0001877184 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.